Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients
European Journal of Cancer2011Vol. 48(13), pp. 2004–2011
Citations Over TimeTop 20% of 2011 papers
Reinhart Speeckaert, Karim Vermaelen, Nanja van Geel, Philippe Autier, Jo Lambert, Marc Haspeslagh, Mireille Van Gele, Kris Thielemans, Bart Neyns, Nathalie Roche, Natacha Verbeke, Philippe Deron, Marijn M. Speeckaert, Liève Brochez
Related Papers
- → How Does Indoleamine 2,3-Dioxygenase Contribute to HIV-Mediated Immune Dysregulation(2007)72 cited
- → Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma(2002)35 cited
- Expression of indoleamine 2,3-dioxygenase in pregnant mice correlates with CD4+CD25+Foxp3+ T regulatory cells.(2017)
- [Surgical treatment of malignant melanoma of the skin and our results].(1966)
- → Melanoma without Sentinel Lymph Node Involvement: Patients Have Increased Risk of Recurrence Detected by DecisionDx-Melanoma(2019)